Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Longitudinal analysis of lipid mediators in post-tuberculosis lung disease identifies significant differences. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Tuberculosis and chronic respiratory disease: a systematic review
10.1016/j.ijid.2014.12.016 · 2015 · External reference
Post-tuberculosis lung health: perspectives from the First International Symposium
10.5588/ijtld.20.0067 · 2020 · External reference
Improving lung health in low-income and middle-income countries: from challenges to solutions
10.1016/s0140-6736(21)00458-x · 2021 · External reference
Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis
10.1371/journal.pgph.0000805 · 2022 · External reference
Quantifying the global number of tuberculosis survivors: a modelling study
10.1016/s1473-3099(20)30919-1 · 2021 · External reference
Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis
10.1016/s1473-3099(19)30309-3 · 2019 · External reference
Tuberculosis and lung damage: from epidemiology to pathophysiology
10.1183/16000617.0077-2017 · 2018 · External reference
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
10.1016/s2213-2600(20)30039-4 · 2020 · External reference
Pro-resolving lipid mediators are leads for resolution physiology
10.1038/nature13479 · 2014 · External reference
Specialized pro-resolving mediator network: an update on production and actions
10.1042/ebc20200018 · 2020 · External reference
Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections
2021 · External reference
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
10.1016/j.ejphar.2015.11.001 · 2016 · External reference
Plasma levels of specialized pro-resolving mediators are associated with the severity of pulmonary tuberculosis
2021 · External reference
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death
10.1084/jem.20080767 · 2008 · External reference
Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden
10.3389/fcimb.2019.00335 · 2019 · External reference
Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
10.1096/fj.201901590r · 2019 · External reference
Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications
10.1177/1753465807082373 · 2007 · External reference
Standardisation of spirometry
10.1183/09031936.05.00034805 · 2005 · External reference
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations
10.1183/09031936.00080312 · 2012 · External reference
Stability and analysis of eicosanoids and docosanoids in tissue culture media
10.1016/j.prostaglandins.2011.01.003 · 2011 · External reference
Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor
10.1096/fj.14-254383 · 2014 · External reference
Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4
10.1096/fj.201600583r · 2016 · External reference
Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome
10.1194/jlr.p069096 · 2016 · External reference
Guiding the choice of informatics software and tools for lipidomics research applications
10.1038/s41592-022-01710-0 · 2023 · External reference
The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values together
2017 · External reference
Eicosanoid storm in infection and inflammation
10.1038/nri3859 · 2015 · External reference
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
10.1172/jci97943 · 2018 · External reference
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
10.1038/nri.2015.4 · 2016 · External reference
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology
10.1128/iai.69.3.1847-1855.2001 · 2001 · External reference
Cytokine and lipid mediator networks in tuberculosis
10.1111/imr.12249 · 2015 · External reference
Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro
10.1371/journal.pone.0129744 · 2015 · External reference
Resolvins, protectins, and maresins: DHA-derived specialized pro-resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation
10.3390/molecules27051677 · 2022 · External reference
ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α
10.1096/fj.202001687r · 2021 · External reference
Regulation of tissue inflammation by 12-lipoxygenases
10.3390/biom11050717 · 2021 · External reference
Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages
10.1152/ajplung.00125.2015 · 2015 · External reference
Specialized pro-resolving mediators as modulators of immune responses
10.1016/j.smim.2022.101605 · 2022 · External reference
Resolvin D1 reduces emphysema and chronic inflammation
10.1016/j.ajpath.2015.08.008 · 2015 · External reference
